US Stocks
/
BriaCell Therapeutics Corp. Share Price
BriaCell Therapeutics Corp. Share Price

BriaCell Therapeutics Corp. Share Price

NASDAQ: BCTX | Micro Cap
$4.00
-$0.09 (-2.32%) Last updated on 08 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

BriaCell Therapeutics Corp. Stock Performance

Open
$4.02
Prev. Close
$4.09
Circuit Range
N/A
Day Range
$3.94 - $4.03
Year Range
$2.60 - $13.78
Volume
1,109
Average Traded
$4.00

BriaCell Therapeutics Corp. Share Price Today

As of 8 October 2026, BriaCell Therapeutics Corp.'s share price is $4.00. The stock opened at $4.02, compared to its previous close of $4.09. During today's trading session, BriaCell Therapeutics Corp.'s share price traded between $3.94 and $4.03, with an average price of $3.99. Over the past 52 weeks, the stock has recorded a high of $13.78 and a low of $2.60. In terms of performance, BriaCell Therapeutics Corp.'s share price has declined by 4.43% over the last six months and is down 66.23% on a year-on-year basis.

BriaCell Therapeutics Corp. Share Price Chart

$3.94$4.03
L
Show Current Price
H

BriaCell Therapeutics Corp. Stock Fundamentals & Key Indicators

Market Cap
$1.69M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.53
Revenue (TTM)
$0.00
Return On Equity (TTM)
-127.51%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
11.50%

BriaCell Therapeutics Corp. Quarterly Profit & Loss

All figures in USD

ParticularsJul 2025Oct 2025Jan 2026Apr 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.09-$8.20-$7.22-$7.16
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-1.36%11.95%0.83%

BriaCell Therapeutics Corp. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$26.84-$20.30-$4.79-$26.31
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A24.37%76.40%-449.27%

About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

BriaCell Therapeutics Corp. Historical Returns

MonthOpenCloseChange %
Oct 2026
$4.16
$3.98
-6.57%
Sep 2026
$3.63
$4.26
+13.90%
Aug 2026
$3.40
$3.74
+3.89%
Jul 2026
$3.40
$3.60
+10.60%
Jun 2026
$3.27
$3.25
-9.83%
May 2026
$4.25
$3.61
-13.64%
Apr 2026
$4.22
$4.18
-0.48%
Mar 2026
$3.69
$4.20
+10.82%
Feb 2026
$4.28
$3.79
-11.96%
Jan 2026
$7.06
$4.30
-39.71%
Dec 2025
$12.29
$7.14
-26.39%
Nov 2025
$10.14
$9.70
-18.01%

BCTX Share Price FAQs

What is BriaCell Therapeutics Corp. share price today?

chevron-up
BriaCell Therapeutics Corp. share price today is $4.00 as on October 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of BriaCell Therapeutics Corp. stock?

chevron-up
The 52 week high of BriaCell Therapeutics Corp. stock is $13.78, while the 52 week low is $2.60 as of 8 Oct '26.

What is BCTX's market capitalisation today?

chevron-up
BCTX market capitalisation is $1.69M as of October 8, 2026, at 4:07 pm IST.

What is BCTX's net income for the last quarter?

chevron-up
BCTX's net income for the last quarter is -7.16B USD.

What is the 5 year returns of BCTX?

chevron-up
The 5 year returns of BCTX is -96.65% as on 8 Oct '26.

What is the high & low stock price of BCTX today?

chevron-up
BCTX stock price hit a high of $4.03 and low of $3.94 as of 8 Oct '26.

Can I buy BCTX shares in India?

chevron-up
Yes. You can buy BCTX in India by opening an international trading account.